en
Scientific article
Open access
English

Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment

Published inBritish Journal of Cancer, vol. 120, no. 2, p. 218-228
Publication date2019
Abstract

In a genomic screen for determinants of the tumour vasculature, we identified insulin receptor (INSR) to mark the tumour endothelium. As a functional role for insulin/INSR in cancer has been suggested and markers of the tumour endothelium may be attractive therapeutic targets, we investigated the role of INSR in angiogenesis.

Keywords
  • Animals
  • Antigens, CD/genetics
  • Cell Proliferation/genetics
  • Chick Embryo
  • Chorioallantoic Membrane/metabolism/pathology
  • Disease Models, Animal
  • Endothelium/metabolism/pathology
  • Female
  • Gene Knockdown Techniques
  • Genome, Human/genetics
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Insulin/genetics/metabolism
  • Kidney Neoplasms/genetics/pathology
  • Male
  • Mice
  • Neovascularization, Pathologic/genetics/pathology
  • Protein Isoforms/genetics
  • RNA, Small Interfering/genetics
  • Receptor, Insulin/genetics
  • Tumor Cells, Cultured
Citation (ISO format)
NOWAK-SLIWINSKA, Patrycja et al. Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment. In: British Journal of Cancer, 2019, vol. 120, n° 2, p. 218–228. doi: 10.1038/s41416-018-0347-8
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0007-0920
244views
112downloads

Technical informations

Creation08/26/2020 1:36:00 PM
First validation08/26/2020 1:36:00 PM
Update time03/15/2023 10:30:08 PM
Status update03/15/2023 10:30:07 PM
Last indexation02/12/2024 11:54:39 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack